A carregar...
Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib
Bleeding because of impaired platelet function is a major side effect of the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib. We quantitatively assessed ristocetin-induced platelet aggregation (RIPA) in 64 patients with chronic lymphocytic leukemia (CLL) under ibrutinib at 287 time points. E...
Na minha lista:
Publicado no: | Leukemia |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Nature Publishing Group
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5338745/ https://ncbi.nlm.nih.gov/pubmed/27909342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2016.316 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|